Related Experiment Videos
Structural and functional properties of apolipoprotein A-I mutants
J Sasaki1, A Matsunaga, W Huang
1Department of Internal Medicine, Fukuoka University School of Medicine, Japan. jsasaki@cis.fukuoka-u.ac.jp
Journal of Atherosclerosis and Thrombosis
|June 28, 2001
Summary
Familial apolipoprotein A-I (apoA-I) deficiency, a rare metabolic disorder, involves genetic mutations affecting HDL metabolism. Some apoA-I mutations do not always lead to coronary artery disease.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Apolipoprotein (apo) A-I is crucial for high-density lipoprotein (HDL) metabolism, comprising 243 amino acid residues forming amphipathic helices.
- Familial apoA-I deficiency is a rare metabolic disorder, with three cases identified in western Japan characterized at a molecular level.
- Coronary artery disease is not consistently observed in individuals with apoA-I deficiency.
Framework:
- Investigated genetic mutations in apoA-I, identifying nine distinct structural mutations through screening.
- Characterized various apoA-I mutations, including the specific apoA-I (Glu235del) Nichinan variant.
- Examined the relationship between structural apoA-I mutations and alterations in HDL cholesterol levels.
Implementation:
- Screening analysis identified nine genetically-determined structural mutations of apo A-I.
- Detailed characterization of identified apo A-I mutations was performed.
- Evaluated the association between specific structural mutations and HDL cholesterol levels.
Implications:
- Understanding the molecular basis of apoA-I deficiency provides insights into HDL metabolism and cardiovascular disease risk.
- Identification of diverse apoA-I mutations expands knowledge of genetic lipid disorders.
- The variable association between apoA-I deficiency and coronary artery disease suggests complex pathogenetic mechanisms.